Skip to main content

What kind of company is Neurelis?

Neurelis is a neuroscience-based specialty pharmaceutical company providing innovative approaches to target unmet medical needs. Our approach combines novel technologies designed to enhance therapeutic benefit and address unmet needs in patient care.

Neurelis was founded to license, develop, and commercialize product candidates for epilepsy, psychiatry, and the broader central nervous system (CNS) market with an emphasis on rescue therapies that empower patients, caregivers, and healthcare providers. Our extensive expertise in the development and commercialization of CNS compounds, combined with our strong relationships with leading researchers and clinicians in these markets, allows us to advance the development of unique product candidates that address significant unmet medical needs. 

The Neurelis Journey

The Neurelis team has more than 160 years of combined relevant neurology industry experience.

Meet the Leadership Team
Meet the Board of Directors